United Therapeutics Corporation
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.26 | 12.34 | 13.64 | 15.05 | 15.47 | 15.11 | 16.35 | 16.53 | 16.90 | 16.50 | 16.56 | 17.10 | 68.88 | |
| 1.41 | 1.43 | 1.47 | 1.64 | 1.72 | 1.56 | 1.90 | 1.81 | 2.13 | 2.16 | 2.83 | 2.17 | 9.55 | |
| 10.85 | 10.92 | 12.17 | 13.41 | 13.76 | 13.55 | 14.44 | 14.72 | 14.77 | 14.34 | 13.73 | 14.93 | 59.33 | |
| 1.70 | 3.04 | 2.09 | 2.94 | 2.14 | 2.75 | 3.07 | 2.77 | 2.70 | 2.91 | 2.93 | 3.19 | 12.04 | |
| 2.15 | 2.17 | 2.44 | 3.20 | 4.10 | 2.78 | 2.95 | 3.31 | 3.25 | 3.28 | 3.29 | 3.01 | 13.19 | |
| 4.27 | 5.69 | 5.00 | 6.68 | 6.67 | 6.21 | 6.57 | 7.17 | 6.54 | 6.87 | 6.83 | 7.71 | 28.69 | |
| 6.58 | 5.22 | 7.17 | 6.73 | 7.09 | 7.34 | 7.88 | 7.55 | 8.23 | 7.46 | 6.90 | 7.22 | 30.64 | |
| 0.31 | 0.30 | 0.27 | 0.24 | 0.21 | 0.16 | 0.13 | 0.15 | 0.06 | 0.06 | 0.06 | 0.06 | 0.26 | |
| 7.08 | 5.93 | 8.02 | 7.48 | 8.03 | 8.14 | 8.71 | 8.46 | 9.26 | 9.27 | 6.74 | 8.14 | 34.34 | |
| 1.69 | 1.57 | 1.85 | 1.63 | 1.64 | 1.95 | 2.08 | 2.05 | 2.10 | 1.66 | 0.92 | 0.87 | 5.72 | |
| 5.38 | 4.36 | 6.17 | 5.85 | 6.39 | 6.19 | 6.63 | 6.41 | 7.16 | 7.61 | 5.82 | 7.27 | 28.62 | |
| 7.66 | 6.51 | 8.59 | 8.12 | 8.63 | 8.71 | 9.00 | 9.04 | 9.79 | 9.81 | 7.29 | 8.20 | 36.08 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.